|1.||Sheu, Ming-Jyh: 1 article (01/2014)|
|2.||Chen, Tsung-Chih: 1 article (01/2014)|
|3.||Lin, Wen-Hsin: 1 article (01/2014)|
|4.||Huang, Hsu-Shan: 1 article (01/2014)|
|5.||Chung, Yun-Lung: 1 article (01/2014)|
|6.||Liou, Wei-Hung: 1 article (01/2014)|
|7.||Wu, Chieh-Hsi: 1 article (01/2014)|
|8.||Pan, Chun-Hsu: 1 article (01/2014)|
|1.||Lung Neoplasms (Lung Cancer)
01/01/2014 - "NSC746364, a G-quadruplex-stabilizing agent, suppresses cell growth of A549 human lung cancer cells through activation of the ATR/Chk1-dependent pathway."
01/01/2014 - "Consequently, our results indicated that NSC746364 may have therapeutic potential as a chemotherapy for non-small-cell lung cancers."
01/01/2014 - "Our study suggested that NSC746364 induced cell cycle arrest at the G2/M phase and triggers programming cell death on A549 human lung cancer cells, whose effects are modulated through the activation of the ATR/Chk1 pathway, the downregulation of cyclin B1 expression, and the activation of caspase-3. "
|2.||Caspase 3 (Caspase-3)
|1.||Drug Therapy (Chemotherapy)